Company / Free Cash Flow per Share
Boston Scientific Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.45
FY2025
5-year range
$0.65 / $2.45
FY2021-FY2025
Trend
+37.5%
vs FY2024
Sector context
#64 of 148
Health Care
What the data says
At $2.45, Boston Scientific's free cash flow per share ranks #64 of 148 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $0.65 in FY2022 to $2.45 in FY2025.
Based on SEC 10-K filings.
2.45 in FY2025 with a 3-year CAGR of +55.5%.
Improved from $1.25 to $2.45 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +55.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 148 in Health CareTop 43% of 148This company $2.45 Sector average $5.05
▼
-51.5% below sector average
Key checks
Key Insights
- Boston Scientific's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 37.5% year-over-year.
- Ranks #64 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.45 | +37.5% |
| FY2024 | $1.78 | +42.4% |
| FY2023 | $1.25 | +91.8% |
| FY2022 | $0.65 | -33.2% |
| FY2021 | $0.97 | +22867.2% |
| FY2020 | -$0.00 | -100.4% |
| FY2019 | $0.99 | +22846.8% |
| FY2018 | -$0.00 | -100.5% |
| FY2017 | $0.81 | +34.7% |
| FY2016 | $0.60 | +78.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026